64x Bio
San Francisco
About 64x Bio
A comprehensive platform and product suite for advanced therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $59.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: 64xbio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/64x-bio-84966 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.